
Please try another search
Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Sydney, Australia.
Name | Age | Since | Title |
---|---|---|---|
James D. Thomas | - | - | Advisory Board Member |
Andrew Grover | - | 2019 | Executive Chairman |
Madeline Jankowski | - | - | Advisory Board Member |
David Ouyang | - | - | Advisory Board Member |
Stephen Frank Picton | - | 2020 | Independent Non-Executive Director |
Steven Allen Formica | - | 2018 | Independent Non-Executive Director |
Jessamyn Sarah Lyons | - | 2021 | Company Secretary & Director |
Hashim A. Khan | - | - | Advisory Board Member |
Huon Hamilton Gray | 71 | - | Advisory Board Member |
Jordan B. Strom | - | - | Advisory Board Member |
Kenneth Nelson | 51 | 2024 | Non-Executive Director |
Michael J. Mack | 78 | - | Advisory Board Member |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review